Monthly Suboxone injection: red flags and questions to ask

If you are researching a monthly Suboxone option, this checklist shows the clinical and program level red flags to identify before you start. Monthly buprenorphine injections are extended release depot formulations administered by a clinician about every four weeks. They differ from daily sublingual buprenorphine/naloxone and from methadone in ways that affect safety, monitoring, and logistics. For Health Canada guidance on opioid use disorder treatment, see the official overview on opioid treatment options: opioids use disorder treatment.html.

What a monthly Suboxone-style injection is and how it differs from daily options

Monthly injections such as extended-release buprenorphine are given subcutaneously by a trained clinician in a medical setting. They release buprenorphine over about four weeks so patients do not need daily tablets or films. Randomized trials and clinical reviews show monthly depot injections are an evidence-based option for moderate to severe opioid use disorder when offered with appropriate monitoring. For trial and review details, see the systematic and trial summaries of extended-release buprenorphine: PMC article.

Road To Recovery includes monthly buprenorphine injections such as Sublocade among medication options for opioid agonist therapy, but site availability varies. Confirm availability before assuming the injection will be offered at first intake.

Induction and common dosing patterns to know

Dosing is not identical for every patient. A commonly used schedule is two monthly 300 mg injections for the first two months, followed by monthly maintenance doses such as 100 mg, though prescribers individualize treatment based on clinical need. This two-dose loading approach and maintenance options are described in regulatory and pharmacoeconomic reviews: see the NCBI pharmacoeconomic review and the FDA product label for dosing details (NCBI review, FDA label).

The FDA label notes that the initial 300 mg dose produces a higher peak plasma level and may cause more buprenorphine-related effects than maintenance dosing. Understanding this helps explain why prescribers may choose a particular induction plan.

Clinical red flags and contraindications patients must check

Before agreeing to a monthly injection, confirm that a clinician completes the checks below. Each item explains why it matters, how to verify it, and an exact question to ask your prescriber.

1. Recent opioid use and timing of induction

Why it matters: Starting buprenorphine too early while using full opioid agonists can precipitate withdrawal. Monthly injections often require careful timing and sometimes stabilization on sublingual buprenorphine first.

• How to check: The prescriber should review your current opioid use, perform an assessment, and explain the induction timeline.
• Ask: “Do I need to be stabilized on sublingual buprenorphine before receiving the monthly injection, and if so, for how long?”

2. Concurrent sedating medications and respiratory risk

Why it matters: Buprenorphine can cause sedation, and the risk increases with benzodiazepines, other sedatives, or heavy alcohol use. The product label warns that higher doses can increase buprenorphine-related effects, including drowsiness and respiratory depression.

• How to check: Provide a complete medication and substance use list and ask how interactions will be managed. The clinic should document a monitoring plan.
• Ask: “Do any of my current medications or alcohol use increase the risk of sedation with the monthly injection, and how will you monitor this?”

3. Injection site history and allergic reactions

Why it matters: Monthly injections require subcutaneous placement. Local site reactions, injection site infection, or hypersensitivity are possible. Clinical trials and product information describe common local effects and recommend observation after administration.

• How to check: The clinic should ask about past injection reactions and show where the injection will be given and how it will be observed.
• Ask: “Have you had reactions to injections before, and what will you do if I develop a local reaction or infection?”

4. Pregnancy, breastfeeding, and reproductive plans

Why it matters: Decisions about buprenorphine in pregnancy or while breastfeeding require specialist input. Discuss risks and benefits with a clinician experienced in perinatal addiction care before switching formulations.

• How to check: Tell the prescriber if you are pregnant, planning pregnancy, or breastfeeding.
• Ask: “Is the monthly injection recommended for pregnancy or breastfeeding, or should I remain on another formulation while arranging specialist care?”

Program and logistics red flags to confirm with a clinic

Non-medical program issues often determine whether monthly injections are a safe and practical choice. Confirm the items below before committing to treatment.

5. Site availability and trained staff

Why it matters: Not every clinic offers monthly injections, and proper administration requires staff trained in the product and prepared to handle potential adverse effects. Confirm that the specific clinic location provides the injection and that clinicians are experienced in administering it.

• How to check: Call the clinic or use the intake portal to verify availability for your preferred location.
• Ask: “Do you provide monthly buprenorphine injections at this site, and which clinicians are trained to give them?”

6. Consistent monthly access and missed dose policy

Why it matters: Monthly injections require timely visits. If you travel, relocate, or miss an appointment, the clinic should have a clear policy so you do not lapse into untreated withdrawal or face a gap in care.

• How to check: Request the clinic’s policy on missed doses and on coverage for travel or extended absences.
• Ask: “What is your missed appointment protocol and how will you manage my dosing if I am travelling or miss a monthly visit?”

7. Integrated mental health and psychiatry support

Why it matters: Medication is one part of effective care. Programs that provide or coordinate mental health and psychiatry support improve outcomes for people with coexisting conditions. Road To Recovery coordinates psychiatry referrals locally or virtually with partners such as CAMH and OTN to support integrated care.

• How to check: Ask how mental health needs are assessed and whether psychiatry referrals are available.
• Ask: “Can you coordinate psychiatry referrals if I need assessment or medication for mood, anxiety, or other conditions?”

Safety monitoring and side effects to watch for after injection

Common side effects reported in clinical guidance include injection site pain, nausea, headache, and sedation. Higher initial 300 mg doses produce higher peak plasma concentrations and therefore a greater chance of buprenorphine-related effects such as drowsiness. The FDA label and trial reports list adverse events and recommend monitoring after injection for safety (FDA label, trial summary).

Seek urgent care if you experience severe difficulty breathing, passing out or near loss of consciousness, or signs of a spreading infection at the injection site. For a plain patient guide summarizing safety information, the VA patient guide offers accessible information about what to expect with extended-release buprenorphine: VA patient guide.

Practical questions to bring to intake in Ontario: one-page checklist

• Do you offer monthly buprenorphine injections at this clinic location, and when is the earliest available appointment?
• Do I need to be stabilized on sublingual buprenorphine before the first injection, and what is your induction plan?
• Which dosing schedule do you expect to use for me, and why might you change it?
• What is your policy for missed monthly injections and for travel or extended absences?
• How do you screen for medication interactions and sedation risk, especially with benzodiazepines or alcohol?
• What training do staff who give the injection have, and who will observe me after the dose?
• Do you provide psychiatry referrals or mental health support, and how are those arranged?
• What are likely side effects after the loading dose versus maintenance doses, and when should I seek urgent help?
• How is confidentiality handled, and will my employer or insurer be contacted without consent?
• Where can I read more about monthly injections and the clinic’s local protocol?

Road To Recovery highlights a secure online intake portal and same day nurse triage followed by physician assessment for new opioid agonist therapy patients, which can reduce wait times. Always confirm whether the clinic can provide the monthly injection at the first visit or whether it will be scheduled for a follow up appointment.

For a clinic-specific explanation of once-monthly care, review Road To Recovery’s Sublocade guide: Sublocade guide.

Common objections and concise responses

Needle anxiety: Ask about techniques to reduce pain and whether staff will stay with you during the injection. Many clinics use practical steps to make the visit easier.

Worry about losing control: Monthly injections are a treatment option that reduces the need for daily dosing. Discuss expectations about cravings, withdrawal, and how the clinic will support transitions between formulations if needed.

Travel or missed appointments: Ask about documented policies. In exceptional cases, a prescriber may use a higher single dose to cover a longer interval, but this is a clinical decision described in product labeling only for specific situations.

Cost and coverage: Coverage varies across public and private plans. Clinics cannot guarantee reimbursement, so ask what billing options exist and whether the clinic can help with coverage inquiries.

How to start at Road To Recovery and what to expect at same-day intake

Road To Recovery operates outpatient clinics across Ontario and uses a secure online intake portal to streamline access. New OAT patients commonly receive nurse triage followed by physician assessment on the same day. This intake flow can speed access to treatment, but whether the monthly injection is given at the same visit depends on site availability and clinical readiness. Confirm availability in advance and bring the checklist above to your appointment.

Frequently asked questions

Who is eligible for a monthly buprenorphine injection like Sublocade

Eligibility is an individual clinical decision. Providers consider the severity of opioid use disorder, recent opioid use, medical history, and medication interactions. Discuss eligibility with a prescriber who will perform an assessment and explain whether you must be stabilized on sublingual buprenorphine first.

How does the induction schedule for a monthly injection usually work

A common approach used in trials and clinical practice is two monthly 300 mg injections followed by monthly maintenance doses such as 100 mg. The exact schedule and dose depend on clinical judgment and patient needs, so ask your clinic for their usual protocol and reasoning.

What are the main side effects and when should I seek urgent care

Typical side effects include injection site pain, nausea, headache, and sedation. Seek urgent care for severe breathing problems, loss of consciousness, or signs of a spreading injection site infection. Ask your prescriber which symptoms require immediate attention.

Can I switch from daily Suboxone to a monthly injection right away

Switching may require stabilization on sublingual buprenorphine and a documented induction plan to avoid precipitated withdrawal. Always discuss transition timing with your prescriber and confirm the clinic’s protocol.

Will a clinic provide the injection if I am travelling or miss an appointment

Clinics have different policies. Some may arrange an adjusted dosing plan or offer limited flexibility in exceptional cases, but you should confirm the missed dose policy and travel options before starting monthly injections.

For reliable regulatory and patient information on monthly buprenorphine injections, see Health Canada and the product label and reviews linked above. When you are ready to start or to ask these questions directly, contact Road To Recovery to check location availability and begin the secure online intake process.